NCT05113810 - The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19 | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

March 20, 2022

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions

2019 Novel Coronavirus

Interventions

DRUG

HCQ01

HCQ01 is a sterile, clear and colorless, ready-to-use aqueous nebulizer solution. Hydroxychloroquine sulfate administered via nebulization

OTHER

standard of care (SOC) for COVID-19

Standard of care (SOC) for COVID-19

Trial Locations (1)

RECRUITING

Prince Hamza Hospital/ Amman Field Hospital, Amman